Terapêutica medicamentosa na isquemia e reperfusão mesentérica: revisão da literatura
暂无分享,去创建一个
[1] Carlos Henrique Marques dos Santos,et al. Uso do propofol (2,6 diisopropilfenol) como inibidor da lesão tecidual na isquemia e reperfusão mesentérica: estudo experimental em ratos , 2003 .
[2] H. Scheld,et al. Diagnosis and treatment of nonocclusive mesenteric ischemia after open heart surgery. , 2001, The Annals of thoracic surgery.
[3] W. B. Yoshida,et al. Estudo da ação do extrato de Ginkgo biloba e amido hidroxietílico hipertônico na atenuação de alterações decorrentes de isquemia e reperfusão de órgãos esplâncnicos em ratos , 2001 .
[4] R. Procianoy,et al. [Hypoxic-ischemic syndrome] , 2001, Jornal de pediatria.
[5] M. Brito,et al. Lesão intestinal após isquemia-reperfusão: estudo comparativo usando sal tetrazólico (MTT) e histologia , 2001 .
[6] S. Kong,et al. Pretreatment With Glycine Reduces the Severity of Warm Intestinal Ischemic-Reperfusion Injury in the Rat , 2001, Annals of plastic surgery.
[7] S. Morini,et al. Pyruvate prevents intestinal functional changes following ischemia-reperfusion injury. , 2001, Transplantation proceedings.
[8] M. Caleb. Acute bowel ischemia after coronary bypass surgery--a catastrophic event. , 2001, Singapore medical journal.
[9] S. Morini,et al. Pyruvate inhibits functional changes following intestinal ischemia-reperfusion injury , 2000 .
[10] P. Tam,et al. Nitric oxide protects segmental intestinal grafts from ischemia and reperfusion injury. , 2000, Transplantation proceedings.
[11] M. Caty,et al. Attenuated nitric oxide synthase activity and protein expression accompany intestinal ischemia/reperfusion injury in rats. , 2000, Biochemical and biophysical research communications.
[12] X. Wu,et al. Supraceliac aortic cross‐clamping and declamping. Effects of dopexamine and dopamine on systemic and mesenteric hemodynamics, metabolism and intestinal tonometry in a rat model , 2000, Acta anaesthesiologica Scandinavica.
[13] T. Shea-Donohue,et al. Sustained nitric oxide production via l-arginine administration ameliorates effects of intestinal ischemia-reperfusion. , 2000, The Journal of surgical research.
[14] Fernando Hintz Greca,et al. Influência do antibiótico nas lesões de isquemia e reperfusão intestinal: estudo experimental em ratos , 2000 .
[15] H. M. Chen,et al. Aminoguanidine attenuates hemodynamic and microcirculatory derangement in rat intestinal ischemia and reperfusion. , 1999, The Journal of trauma.
[16] İ. Durak,et al. Enzymatic antioxidant defence mechanism in rat intestinal tissue is changed after ischemia-reperfusion. Effects of an allopurinol plus antioxidant combination. , 1999, Canadian journal of surgery. Journal canadien de chirurgie.
[17] E. Deveci,et al. Histopathological assessment of the prophylactic effect of gingko-biloba extract on intestinal ischemia-reperfusion injury. , 1999, Acta gastro-enterologica Belgica.
[18] J. V. Ferrer,et al. Metabolism of the intestine with intermediate ischemia after intestinal ischemia-reperfusion injury: therapeutic effects of somatostatin. , 1999, Transplantation proceedings.
[19] A. Eidelman,et al. Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. , 1999, Journal of pediatric gastroenterology and nutrition.
[20] Tufi Neder Meyer,et al. Resposta celular ao estresse , 1999 .
[21] M. A. Holanda,et al. Lesão pulmonar de reperfusão , 1999 .
[22] A. Eker,et al. Mesenteric ischemia after coronary artery bypass grafting: should local continuous intra-arterial perfusion with papaverine be regarded as a treatment? , 1999, European Journal of Cardio-Thoracic Surgery.
[23] Ç. Durakbaşa,et al. Nitric oxide and endothelin relationship in intestinal ischemia/reperfusion injury , 1998 .
[24] A. Dursun,et al. Role of endogenous endothelin peptides in intestinal ischemia-reperfusion injury in rats. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.
[25] J. V. Ferrer,et al. Allopurinol and N-acetylcysteine avoid 60% of intestinal necrosis in an ischemia-reperfusion experimental model. , 1998, Transplantation proceedings.
[26] T. Starzl,et al. Protective Effect of TNF-α and IL-1β Inhibitor FR167653 on Ischemia-Reperfusion Injury in Rat Small Intestinal Transplantation , 1998 .
[27] Y. Yao,et al. The role of gut as a cytokine-generating organ in remote organ dysfunction after intestinal ischemia and reperfusion. , 1998, Chinese medical journal.
[28] M. Kataoka,et al. Inhibition by aminosalicylates of lipid peroxidation in large intestinal mucosa after mesenteric ischemia/reperfusion in the rat. , 1997, Japanese journal of pharmacology.
[29] M. Caty,et al. Mucosa cell regeneration following intestinal ischemia/reperfusion injury in rats. , 1997, Chinese medical journal.
[30] M. Boros,et al. Ischemia time dependency of reperfusion injury following complete arterial occlusion of the rat small intestine. , 1995, Transplantation proceedings.
[31] N. Vaziri,et al. Hypoxia-induced alterations of neutrophil membrane receptors. , 1995, The Journal of surgical research.
[32] A. Marston. Acute intestinal ischaemia. , 1990, BMJ.
[33] D. Granger,et al. Contributions of ischemia and reperfusion to mucosal lesion formation. , 1986, The American journal of physiology.
[34] Ming Al. Retransplantation of the cornea. , 1971 .
[35] H. Scott,et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.